Skip to content

RHO Phyto™

The Future of Cannabinoid-Based Medicine

RHO Phyto™

The Future of Cannabinoid-Based Medicine

Medical Cannabis Products and RHO Phyto™

The formulary of proprietary medical cannabis products marketed are under the RHO Phyto™ brand and offer a range of scientifically driven formulations in a variety of formats including oral, sublingual, topical, and transdermal with varying ratios of cannabinoids including CBD, THC and CBG. Rho Phyto products and formulations are now commercial in several countries including Canada, US, Germany, and Barbados. In Canada the RHO Phyto products are available in Canada across adult use and several medical cannabis channels including MyMedi.ca.

University Health
Network

Medical Cannabis by Shoppers Commercial Portal

Including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data

Visit Medical Cannabis by Shoppers to view RHO Phyto formulations

Canada’s leading pharmacy retailer with more than 30,000+ registered cannabis patients

Collaborative education and training strategy with clinics in the medical community

Successful segmentation medical patients and aging population

51%

women

75%

sales are to 41+ years of age

Clinical Channels

Sunnybrook Hospital: first medical cannabis brand to be available for dispensing in major hospital pharmacy

UHN-RWET: University Health Network medical cannabis real world evidence study

Commercial Channels

Commercial across Canada, Colombia and Barbados

Commercial across 3 channels in Canada including Adult Use, Clinical and Medical in partnership with Medical Cannabis by Shoppers

Adult use channel. Establishing the wellness category in partnership with retailers across – ON, AB, NB, SK and NB

Visit Us